Pharmacokinetic interaction study [Regulatives / Guidelines]

posted by Mahesh M – India, 2016-05-12 09:07 (3343 d 13:13 ago) – Posting: # 16296
Views: 4,584

Dear All,
My concern regarding Pharmacokinetic interaction study for new combination product, what are the criteria for passing (or how we can say not interact with each other) the Pharmacokinetic interaction study? Is it same as conventional Bioequivalence study criteria (90% CI 80 – 125%).

Please share If any guidance or literature available.

Thanks

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,686 registered users;
80 visitors (0 registered, 80 guests [including 14 identified bots]).
Forum time: 22:20 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5